Literature DB >> 16512876

Stat3 activation is required for cell proliferation and tumorigenesis but not for cell viability in cutaneous squamous cell carcinoma cell lines.

Naoko Sumita1, Toshinori Bito, Koichi Nakajima, Chikako Nishigori.   

Abstract

Signal transducer and activator of transcription 3 (Stat3), a cytoplasmic transcription factor, is constitutively activated in various types of cancer. Previous investigations have demonstrated that Stat3 plays important roles in cell growth, survival, differentiation, and transformation. The constitutive activation of Stat3 in human malignancies is an important key to maintain the characteristics of a malignant tumor, such as the rate of proliferation and/or immortalization, and inhibition of Stat3 function could be a potent therapeutic approach. In order to elucidate the role of Stat3 in tumors, cutaneous squamous cell carcinoma (SCC) cells, which have constitutive activation of Stat3 in vivo and in vitro, were used for this study. To investigate the effect of specific inhibition of Stat3 in SCC cells, we developed small interfering RNAs (siRNAs) that target Stat3, and which effectively prevent its expression in vitro. Introduction of Stat3 siRNA into SCC cells led to inhibition of growth and changes in morphology but did not induce apoptosis. Stat3 siRNA-transfected SCC cells had impaired tumor growth in nude mice. These findings demonstrate that Stat3 plays a critical role in the tumorigenesis, but not in the cell survival, of SCC cells and suggest that additional pro-apoptotic signals are necessary for the induction of apoptosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16512876     DOI: 10.1111/j.0906-6705.2006.00407.x

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  12 in total

1.  Humanized Lewis-Y specific antibody based delivery of STAT3 siRNA.

Authors:  Yuelong Ma; Claudia M Kowolik; Piotr M Swiderski; Marcin Kortylewski; Hua Yu; David A Horne; Richard Jove; Otavia L Caballero; Andrew J G Simpson; Fook-Thean Lee; Vinochani Pillay; Andrew M Scott
Journal:  ACS Chem Biol       Date:  2011-07-26       Impact factor: 5.100

Review 2.  Phytochemicals for the Prevention of Photocarcinogenesis.

Authors:  Mary K Montes de Oca; Ross L Pearlman; Sarah F McClees; Rebecca Strickland; Farrukh Afaq
Journal:  Photochem Photobiol       Date:  2017-03-14       Impact factor: 3.421

3.  PAI-1 Regulates the Invasive Phenotype in Human Cutaneous Squamous Cell Carcinoma.

Authors:  Jennifer Freytag; Cynthia E Wilkins-Port; Craig E Higgins; J Andrew Carlson; Agnes Noel; Jean-Michel Foidart; Stephen P Higgins; Rohan Samarakoon; Paul J Higgins
Journal:  J Oncol       Date:  2010-03-01       Impact factor: 4.375

4.  Identification of a Stat3-dependent transcription regulatory network involved in metastatic progression.

Authors:  Jill J Ranger; David E Levy; Solmaz Shahalizadeh; Michael Hallett; William J Muller
Journal:  Cancer Res       Date:  2009-08-18       Impact factor: 12.701

5.  NVP-BEZ235 or JAKi Treatment leads to decreased survival of examined GBM and BBC cells.

Authors:  Neftali Vazquez; Alma Lopez; Victoria Cuello; Michael Persans; Erin Schuenzel; Wendy Innis-Whitehouse; Megan Keniry
Journal:  Cancer Treat Res Commun       Date:  2021-02-17

6.  Inhibition of Epidermal Growth Factor Receptor and PI3K/Akt Signaling Suppresses Cell Proliferation and Survival through Regulation of Stat3 Activation in Human Cutaneous Squamous Cell Carcinoma.

Authors:  Toshinori Bito; Nahoko Sumita; Masashi Ashida; Arief Budiyanto; Masato Ueda; Masamitsu Ichihashi; Yoshiki Tokura; Chikako Nishigori
Journal:  J Skin Cancer       Date:  2010-12-08

7.  Role of p38 MAPK and STAT3 in lipopolysaccharide-stimulated mouse alveolar macrophages.

Authors:  Aihong Meng; Xiaopeng Zhang; Yuna Shi
Journal:  Exp Ther Med       Date:  2014-10-15       Impact factor: 2.447

8.  IFNalpha and IFNlambda differ in their antiproliferative effects and duration of JAK/STAT signaling activity.

Authors:  Stephen G Maher; Faruk Sheikh; Anthony J Scarzello; Ana L Romero-Weaver; Darren P Baker; Raymond P Donnelly; Ana M Gamero
Journal:  Cancer Biol Ther       Date:  2008-04-24       Impact factor: 4.742

9.  Everolimus-induced human keratinocytes toxicity is mediated by STAT3 inhibition.

Authors:  Kazuhiro Yamamoto; Atsushi Uda; Akira Mukai; Kazuhiko Yamashita; Manabu Kume; Hiroo Makimoto; Toshinori Bito; Chikako Nishigori; Takeshi Hirano; Midori Hirai
Journal:  J Exp Clin Cancer Res       Date:  2013-10-25

10.  MiR-204 silencing in intraepithelial to invasive cutaneous squamous cell carcinoma progression.

Authors:  Agustí Toll; Rocío Salgado; Blanca Espinet; Angel Díaz-Lagares; Eugenia Hernández-Ruiz; Evelyn Andrades; Juan Sandoval; Manel Esteller; Ramón M Pujol; Inmaculada Hernández-Muñoz
Journal:  Mol Cancer       Date:  2016-07-25       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.